Zura Bio (ZURA) Enterprise Value Growth (1y) (2022 - 2026)
Zura Bio (ZURA) Enterprise Value Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Zura Bio | 609.37 Mn | 609.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.44% |
| Dec 31, 2025 | 31.21% |
| Sep 30, 2025 | 30.18% |
| Jun 30, 2025 | 18.16% |
| Mar 31, 2025 | -91.51% |
| Dec 31, 2024 | -96.09% |
| Sep 30, 2024 | -82.45% |
| Jun 30, 2024 | -67.99% |
| Mar 31, 2024 | -100.80% |
| Dec 31, 2023 | -5,075.88% |
| Sep 30, 2023 | -3,255.79% |
| Jun 30, 2023 | -2,421.78% |
| Mar 31, 2023 | -831.42% |
| Dec 31, 2022 | -114.89% |